A high content clonogenic survival drug screen identifies mek inhibitors as potent radiation sensitizers for KRAS mutant non-small-cell lung cancer
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Jessica M Molkentine Howard D. Thames John V Heymach |
| Publication date | July 1, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |